Arbutus Biopharma Statistics
Total Valuation
ABUS has a market cap or net worth of $824.19 million. The enterprise value is $749.71 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABUS has 196.94 million shares outstanding. The number of shares has increased by 3.23% in one year.
| Current Share Class | 196.94M |
| Shares Outstanding | 196.94M |
| Shares Change (YoY) | +3.23% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 49.24% |
| Float | 126.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 59.43 |
| Forward PS | 309.65 |
| PB Ratio | 10.69 |
| P/TBV Ratio | 10.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 53.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.73, with a Debt / Equity ratio of 0.05.
| Current Ratio | 15.73 |
| Quick Ratio | 15.52 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -278.88 |
Financial Efficiency
Return on equity (ROE) is -38.52% and return on invested capital (ROIC) is -18.35%.
| Return on Equity (ROE) | -38.52% |
| Return on Assets (ROA) | -14.94% |
| Return on Invested Capital (ROIC) | -18.35% |
| Return on Capital Employed (ROCE) | -30.53% |
| Weighted Average Cost of Capital (WACC) | 8.28% |
| Revenue Per Employee | $741,211 |
| Profits Per Employee | -$1.76M |
| Employee Count | 19 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.63% in the last 52 weeks. The beta is 0.74, so ABUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +29.63% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 4.23 |
| Relative Strength Index (RSI) | 41.86 |
| Average Volume (20 Days) | 1,648,357 |
Short Selling Information
The latest short interest is 16.17 million, so 8.21% of the outstanding shares have been sold short.
| Short Interest | 16.17M |
| Short Previous Month | 16.41M |
| Short % of Shares Out | 8.21% |
| Short % of Float | 12.77% |
| Short Ratio (days to cover) | 5.56 |
Income Statement
In the last 12 months, ABUS had revenue of $14.08 million and -$33.50 million in losses. Loss per share was -$0.17.
| Revenue | 14.08M |
| Gross Profit | -11.16M |
| Operating Income | -27.05M |
| Pretax Income | -33.50M |
| Net Income | -33.50M |
| EBITDA | -26.69M |
| EBIT | -27.05M |
| Loss Per Share | -$0.17 |
Full Income StatementBalance Sheet
The company has $91.47 million in cash and $4.19 million in debt, with a net cash position of $87.28 million or $0.44 per share.
| Cash & Cash Equivalents | 91.47M |
| Total Debt | 4.19M |
| Net Cash | 87.28M |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 76.58M |
| Book Value Per Share | 0.40 |
| Working Capital | 88.45M |
Full Balance SheetCash Flow
| Operating Cash Flow | -39.64M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 363,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -39.64M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
Gross margin is -79.23%, with operating and profit margins of -192.08% and -237.88%.
| Gross Margin | -79.23% |
| Operating Margin | -192.08% |
| Pretax Margin | -237.88% |
| Profit Margin | -237.88% |
| EBITDA Margin | -189.51% |
| EBIT Margin | -192.08% |
| FCF Margin | n/a |
Dividends & Yields
ABUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -4.00% |
| FCF Yield | -4.74% |
Analyst Forecast
The average price target for ABUS is $5.00, which is 19.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 19.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABUS has an Altman Z-Score of 3.54 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 4 |
